These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6118081)

  • 1. Symposium on reversible chronic obstructive airway disease and the clinical application of albuterol. January 28, 1981, Washington, D.C.
    Ann Allergy; 1981 Nov; 47(5 Pt 2):375-428. PubMed ID: 6118081
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effects of albuterol aerosol in reversible obstructive airway disease.
    Falliers CJ
    Ann Allergy; 1981 Nov; 47(5 Pt 2):387-91. PubMed ID: 7305078
    [No Abstract]   [Full Text] [Related]  

  • 3. The place for albuterol aerosol in chronic obstructive airway disease: maximizing its use.
    Middleton E
    Ann Allergy; 1981 Nov; 47(5 Pt 2):427-8. PubMed ID: 6795977
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparison of a microcrystalline theophylline tablet and salbutamol in reversible airways obstruction.
    Tedders JG; Thomas AK; Edwards G
    Br J Clin Pract; 1976; 30(11-12):212-6. PubMed ID: 795447
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
    Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
    Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of bronchodilation in chronic reversible airways obstruction. Comparison between choline theophyllinate and salbutamol.
    Tanser AR
    Practitioner; 1982 Mar; 226(1365):569-71. PubMed ID: 7045848
    [No Abstract]   [Full Text] [Related]  

  • 7. Seattle's breath of fresh air.
    Wade D
    JEMS; 2000 Jan; 25(1):26-7. PubMed ID: 10977739
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of oral salbutamol and ephedrine in chronic obstructive pulmonary disease.
    Kamat SR; Hoskote VR; Store SD; Sanghavi B; Sheth UK
    Indian J Chest Dis Allied Sci; 1978 Apr; 20(2):54-62. PubMed ID: 363609
    [No Abstract]   [Full Text] [Related]  

  • 9. [Abolition of the salbutamol-induced bronchodilating effect during bronchial infection in patients with chronic obstructive bronchopulmonary diseases].
    Frans A
    Presse Med; 1992 Apr; 21(13):631. PubMed ID: 1534610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic action of salbutamol as compared with orciprenaline in patients with chronic obstructive bronchopneumopathy. Double-blind study].
    Vesco R; Sussi GW
    Minerva Med; 1976 Apr; 67(17):1155-9. PubMed ID: 772479
    [No Abstract]   [Full Text] [Related]  

  • 11. [Over-8-hour salbutamol effect in obstructive respiratory tract diseases].
    Kersten W
    Fortschr Med; 1974 Apr; 92(11):487-91. PubMed ID: 4822455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the effects of salbutamol in chronic obstructive bronchopneumopathies].
    Camerota G; Pontiggia P; Curti PC
    Minerva Med; 1976 Mar; 67(16):1025-6. PubMed ID: 1264376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and physiopathological study of obstructive bronchopneumopathies treated with salbutamol].
    Giuliano V; Martelli GC; Verrua D
    Minerva Med; 1976 Mar; 67(16):1067-9. PubMed ID: 1264382
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
    Barnes D; Delaney JC
    Br J Clin Pract; 1988 Sep; 42(9):372-6. PubMed ID: 2978246
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long acting bronchodilators in chronic obstructive pulmonary disease.
    Griffiths I
    N Z Med J; 1997 Oct; 110(1054):402-3. PubMed ID: 9397087
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in blood gases after inhalation of salbutamol in patients with chronic obstructive bronchopneumopathy].
    Vulterini S; Bianco MR; Pellicciotti L; Sussi G
    Minerva Med; 1976 Mar; 67(15):969-73. PubMed ID: 1264369
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled powder and aerosol salbutamol in metacholine-induced bronchial obstruction.
    Lahdensuo A; Sovijärvi A; Muittari A
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():515-7. PubMed ID: 6352312
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Weir DC; Burge PS
    Thorax; 1990 Nov; 45(11):907-8. PubMed ID: 2256027
    [No Abstract]   [Full Text] [Related]  

  • 20. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
    Fiora L
    Minerva Med; 1976 Apr; 67(17):1165-75. PubMed ID: 1264395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.